COLL
NASDAQ · Pharmaceuticals
Collegium Pharmaceutical Inc
$23.39
+0.35 (+1.52%)
Open$23.39
Previous Close$23.04
Day High$23.47
Day Low$23.06
52W High$50.79
52W Low$21.65
Volume—
Avg Volume914.4K
Market Cap728.59M
P/E Ratio15.21
EPS$1.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+105.9% upside
Current
$23.39
$23.39
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 629.11M | 528.93M | 486.77M |
| Net Income | 50.67M | 38.34M | 68.71M |
| Profit Margin | 8.1% | 7.7% | 14.1% |
| EBITDA | 135.26M | 108.03M | 134.63M |
| Free Cash Flow | — | — | 97.48M |
| Rev Growth | +18.9% | +18.9% | +18.7% |
| Debt/Equity | 3.09 | 3.09 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |